The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Does The Forecasted Market Size Of The Implantable Infusion Pumps Market Compare Between 2026 And 2030?
The implantable infusion pumps market size has shown significant expansion in recent years. It is anticipated to increase from $20.32 billion in 2025 to $21.73 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. The drivers for this growth historically include the rising prevalence of chronic pain conditions, an increase in diabetes cases, an expansion in oncology treatment procedures, improvements in implantable pump technology, and the broadening of specialty clinical care.
The implantable infusion pumps market size is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $28.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This anticipated growth is driven by several factors, including the increasing integration of smart infusion technologies, a rising need for remote patient observation, the broadening of personalized dosing strategies, expanding investments in digital therapeutics, and the increased deployment of implantable pumps in homecare environments. Key developments anticipated within this timeframe involve the growing acceptance of programmable infusion devices, an escalating requirement for lasting pain management therapies, the expanding utilization of intelligent and networked pumps, the enlargement of implantable insulin administration systems, and a heightened emphasis on precise dosage delivery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp
Which Major Factors Are Contributing To The Development Of The Implantable Infusion Pumps Market?
The expanding aging demographic is projected to stimulate the growth of the implantable infusion pumps market. This demographic represents the proportion of individuals aged 65 and above relative to the employed population between 18 and 64. Its rise stems from enhanced life expectancy, driven by improvements in healthcare and living standards, allowing more people to live longer. Given that implantable infusion pumps are commonly employed for managing chronic conditions, an older population naturally translates into a larger pool of potential patients who could benefit from these medical devices. For example, Eurostat, the European Union’s statistical office based in Luxembourg, reported that in February 2025, the European Union’s population in 2024 was estimated at around 449 million. Of this, over one-fifth, or 21.6%, were aged 65 years and over, with a median age of 44.7 years. Furthermore, the old-age dependency ratio in the EU saw an increase of half a percentage point (0.5 pp) from 33.4% in 2023 to 33.9% in 2024. Consequently, the growing aging population is a key driver for the expansion of the implantable infusion pumps market.
How Is The Implantable Infusion Pumps Market Distributed Across Key Segments?
The implantable infusion pumps market covered in this report is segmented –
1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types
2) By Applications: Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps
2) By Enteral Pumps: Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps
3) By Insulin Pumps: Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps
4) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
5) By Syringe Pumps: Small Volume Syringe Pumps, Large Volume Syringe Pumps
6) By Other Types: Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps
Which Trends Are Influencing The Expansion Of The Implantable Infusion Pumps Market?
Leading companies within the implantable infusion pumps market are actively developing new products, such as insulin pumps, to attract a wider customer base, increase sales, and boost revenue. Insulin pumps are medical devices specifically designed to assist individuals with diabetes in effectively managing their blood sugar levels. For example, in April 2023, Medtronic, an Ireland-based medical device company, announced that its MiniMed 780G System, which incorporates meal detection technology, had received FDA approval. A notable attribute of this product is its capability to set the lowest glucose target at 100 mg/dL among all automated insulin pumps available, thereby closely emulating the average glucose levels of non-diabetic individuals. This configuration allows the pump to operate on a treat-to-target approach, automatically making basal insulin adjustments and autocorrections to achieve a specified target. Moreover, it is distinct as the sole pump equipped with an infusion set that can be comfortably worn for an extended period of up to 7 days. This prolonged wear time is achieved through the use of advanced materials that minimize insulin preservative loss and maintain consistent insulin flow and stability, ultimately decreasing the probability of infusion set occlusion.
Who Are The Major Companies Operating In The Implantable Infusion Pumps Market?
Major companies operating in the implantable infusion pumps market are Medtronic plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.
Access The Complete Implantable Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Which Area Represents The Largest Portion Of The Implantable Infusion Pumps Market?
North America was the largest region in the implantable infusion pumps market in 2025. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Implantable Infusion Pumps Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Browse Through More Reports Similar to the Global Implantable Infusion Pumps Market 2026, By The Business Research Company
Infusion Pump Market Report 2026
https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report
Ambulatory Iv Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model